Tria completes equity, debt financing; two board members named
DUBLIN, Calif. — Tria Beauty, which creates at-home light-based skin care products, has announced the completion of $27 million in equity and $10 million in debt financing to help support the continued growth of the company and global commercialization of its light-based skin care products.
"This new financing allows Tria to continue its exceptional growth by introducing our existing products to consumers worldwide, while continuing to invest in the development and clinical validation of new light-based treatments that address consumers’ most important skin care concerns," stated Kevin Appelbaum, Tria Beauty CEO.
"We remain focused on fulfilling our promise to consumers that Tria will continue to bring innovative skin care treatments out of the doctor’s office and into the home, delivering a level of performance never before available over the counter and at an affordable cost," Appelbaum added.
Tria Beauty also announced the addition of two new members to its board of directors: Mike Valentino and Ed Unkart.
Valentino joins after serving as president and CEO of Xanodyne Pharmaceuticals and previously of Adams Respiratory Therapeutics. Adams completed its initial public offering in July 2005 and in December 2007 entered into a definitive agreement to be acquired by Reckitt Benckiser for approximately $2.3 billion.
Ed Unkart joins the Tria board of directors following tenures as CFO at such medical device companies as SurgRx (acquired by Ethicon Endo-Surgery), Novacept (acquired by Cytyc) and FemRx (acquired by Johnson & Johnson). Unkart also will serve as chairman of the audit committee for Tria Beauty.
Tria Beauty has developed the Tria laser hair removal system, an FDA-cleared hair removal laser available for at-home use. In 2010, Tria introduced its skin clarifying system, combining an FDA-cleared blue light treatment for mild to moderate inflammatory acne with a cleanser and serum for overall complexion improvement.
Capital Soleil line of sun care products coming to retail
NEW YORK — Vichy Labs has developed Capital Soleil, a new line of sun care products that will be sold at select CVS/pharmacy, Duane Reade and Walgreens locations.
This new full range of sun care products features an advanced UV filtering system to provide broad-spectrum UVA/UVB protection, and employs an antioxidant combination of white grape polyphenols and vitamin E that helps provide cellular protection and neutralizes almost all types of skin-aging free radicals, the manufacturer stated.
A daily face protection fluid utilizing "shaka shaka" technology to deliver an ultra-sheer, matte application highlights the line. A partial emulsion, the fluid is packaged with two separate components — oil and water — that are combined by an enclosed ball bearing when shaken before application, making the "shaka shaka" sound.
This dispensing innovation in the Capital Soleil SPF 50 Ultra Light sunscreen fluid provides a sheer consistency. With a virtually transparent and smooth finish, the Capital Soleil SPF 50 is ideal for everyday use and for use under makeup.
The new range also features two sunscreen lotions: Capital Soleil Soft Sheer sunscreen lotion SPF 60 and SPF 30.
The Capital Soleil sunscreen line includes the following three products:
Capital Soleil SPF 50 Ultra Light sunscreen fluid ($24.50): This formula provides daily facial sun protection and helps fight free radicals to prevent signs of sun-induced aging. Employing "shaka shaka" technology, this fluid has a sheer and nongreasy finish that is ideal for daily use; and
Capital Soleil Soft Sheer sunscreen lotion SPF 60 ($29.50) and SPF 30 ($27.50): Both sunscreen lotions contain a combination of UV filters with antioxidants. These fragrance-free, water-resistant formulas were developed for sensitive skin, and Capital Soleil SPF 60 is pediatrician-tested.
Capital Soleil Soft Sheer sunscreen lotions will launch in May, while the Capital Soleil SPF 50 Ultra Light sunscreen fluid will launch in July.
Redken recalls spray mousse foam cans
NEW YORK — Redken has announced that it is recalling spray mousse foam cans sold at beauty supply stores and hair salons because of potential rupture.
Over time the aerosol containers’ inside lining can corrode, creating the potential risk of rupturing and releasing the contents. Nearly 1 million cans have been recalled, according to the manufacturer.
Affected hair styling products include Redken Guts 10 Volume spray mousse foam sold in 10.58- and 2-oz. size cans. The product comes in a silver container with “Redken” and “10″ printed on the front of the product in black writing.
The foaming mousse is manufactured in the United States and was distributed and sold at beauty supply stores and hair salons nationwide from January 1998 through February 2011 for between $4 and $16.
The product can be identified by a lot code printed on the bottom of the can. Lot codes included in this recall comprise 32G10Y, 32G11Y, 32G20Y, 32G21Y, 32G23Y, 32G40Y, 32G41Y, 32G60Y, 32G61Y, 32G62Y and 32G70Y.